alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
NO. 07-07 -040 5-CR IN THE CO URT OF APPEA LS FO R THE S EVEN TH D ISTRI CT O F TEXAS

AT AM AR ILLO PAN EL B JU NE 17, 2008

_________

_________

_________

___ LEE OLIVE R BROUSSARD, APP ELL ANT

V. THE S TATE OF TEXAS, APPEL LEE

_________

_________

_________

______ FRO M T HE 25 2 ND DI ST RI CTCOU RTOF J EF FE RS ON COU NT Y; NO . 432 30; H ON ORABLE LAY NE W ALKER , J UD GE

_________

_________

_________

____ Before QUINN, C.J., and CAMPBELL and HANCOCK, JJ. A BA TEMENT A ND R EMA ND App ellantL ee Oliv er B roussa rd a ppe als f rom an orde r denying post -conviction DNA testin g. T he clerk’s record was f iled on Nov em ber 16, 200 7. A supp lem ent al clerk’s record was filed on M ay

5, 2008. Nei ther the cl er k’ s rec ord nor the suppl emental cl er k’ s record c ontai ns a c erti ficat ion by the trial court of

app ellant ’s ri ght of

app eal un der T exas Rule of Appe llate P ro cedu re 25. 2(d). Rule 25 requires the trial court to ent er such a certif ication “each tim e it ente rs a2

ju dgme nt of guilt or oth er app eala ble order.” T ex. R. App
. P. 25.2(a)(2). Co u rt s h a ve re qui re d ce rt i f i c a t i o n of th e righ t t o ap p e a l o rd e rs d e n ying p o st -co n vict io n DNAte st in g. See, e.g., R odr

igu ez v. Sta te, 153 S.W .3d 2 45 ( Tex .App. –El Pas o 2004) , aff’ d No. 08- 04- 00178- CR , 200 5 W L 23136 37 ( Tex .App. –El Pas o Sept . 22, 2005)( m e m . op., not desi g nated for publ ic ati on) ; Lopez v. Sta te, 114 S.W .3d 7 11 ( Tex .App. –Co rp us Chr is ti 2003, no pet .) . F oll ow ing the pla in la ng uag e of Rule 25.2, w e f ind ce rt ific ati on i s req uired here. Con seq uentl y , we abat e thi s a ppeal and re mand the ca use to t h e t ria l court for further proceed ing s. On re mand, t he tr ial co urt s hal l uti li z e w hatev er means nec ess ar

y to sec ure a C erti ficat ion of Defendant ’sR ig ht o f Appea l in compl ian ce w it h Texas Rul e of App ellate Proced ure 25 .2(d), regarding appe llant’s app eal of the trial court’s denial of his re q uestfor p ost -c onv icti on D NA tes ti ng . This ce rt ificat ion mustco mply w it h the re q uirements effect ive Sept ember 1, 2007. Onc e execut ed, th e c e rtific ati on s hal l be inc lud ed i n a s uppl emental cl er k’ s record a n d f ile d wit h thi s C our t on or before Jul y

14, 2008. It isso ordered.

Per C ur iam

Do not p ubl is h.
EXHIBIT 32.2
 CFO CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350, AS ADDED BY SECTION 906 OF THE
SARBANES  OXLEY ACT OF 2002
   (i)
    
    the Form 10-Q fully complies with the requirements of section 13(a) or section
15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m(a) or 78o(d)); and(ii)
    
    the information contained in the Form 10-Q fairly presents, in all material
respects, the financial condition and results of operations of the Issuer.
  /s/ Robert CoppleRobert CoppleChief Financial Officer  /s/ Carol WaldmanName:
    Carol WaldmanTitle:    Notary Public
EX-10.36






EXHIBIT 10.36




DIRECTOR FEE SUMMARY




     Set forth below is a summary of the current director fee arrangements for non-employee
directors serving on the Boards of Directors of Mercantile Bank Corporation (“Mercantile”) and its
wholly owned subsidiary, Mercantile Bank of Michigan (“Bank”).



     For 2009, non-employee directors of the Bank are paid an annual retainer of $5,000, and a fee
of $350 for each meeting of the Board of Directors of the Bank that they attend. In addition,
non-employee directors are paid a meeting fee of $350 for each meeting of the Audit Committee, $300
for each meeting of the Compensation Committee and the Governance and Nominating Committee, and
$200 for each meeting of other committees of the Board of Directors of the Bank that they attend.
Non-employee directors are also paid fees of the same amount for meetings of Mercantile’s Board of
Directors and its committees, when for Board meetings there is not also a meeting of the Board of
Directors of the Bank on the same day, and for committee meetings when there is not also a meeting
of a committee of the Board of Directors of the Bank having the same name or function on the same
day. For meetings that are held by telephone or other remote communications equipment, the meeting
fees are half the amount described above. One annual retainer fee is also paid to each director who
serves as Chairman of the Audit Committees, the Compensation Committees and the Governance and
Nominating Committees of Mercantile’s and the Bank’s Boards of Directors. The annual retainer is,
for the Chairman of the Audit Committees — $3,000, for the Chairman of the Compensation Committees
— $2,000, and for the Chairman of the Governance and Nominating Committees — $2,000.



     The same persons currently serve on the Boards of Directors of Mercantile and the Bank. Under
the Bank’s deferred compensation plan for non-employee directors, directors may elect to defer the
receipt of the annual retainer and meeting fees until they are no longer serving on the Board or
until specific dates that they select. Directors are eligible to receive stock-based awards under
the Stock Incentive Plan of 2006.



1
Exhibit 12.1
 GENERAL CABLE CORPORATION AND SUBSIDIARIES
 Computation of Ratio of Earnings to Fixed Charges
(in millions)
 Three FiscalMonthsEndedApril 3,
    
    
    Year ended December 31,2009
    
    
    2008
    
    
    2007
    
    
    2006
    
    
    2005
    
    
    2004EARNINGS AS DEFINEDEarnings (loss) from operations before income taxes and
before
adjustments for minority interests in consolidated
subsidiaries and after eliminating undistributed earnings
of equity method investees
    
    $
    74.7
    
    
    $
    338.4
    
    
    $
    307.8
    
    
    $
    204.3
    
    
    $
    61.5
    
    
    $
    18.5Preferred stock dividend (pre-tax equivalent)
    
    
    (0.1
    )
    
    
    (0.3
    )
    
    
    (0.5
    )
    
    
    (0.5
    )
    
    
    (33.8
    )
    
    
    (9.2
    )Fixed charges
    
    
    23.8
    
    
    
    73.2
    
    
    
    52.5
    
    
    
    43.3
    
    
    
    76.7
    
    
    
    49.4TOTAL EARNINGS, AS DEFINED
    
    $
    98.4
    
    
    $
    411.3
    
    
    $
    359.8
    
    
    $
    247.1
    
    
    $
    104.4
    
    
    $
    58.7FIXED CHARGES, AS DEFINEDInterest expense
    
    $
    21.3
    
    
    $
    61.0
    
    
    $
    43.9
    
    
    $
    36.9
    
    
    $
    36.5
    
    
    $
    35.0Amortization of capitalized expenses related to debt
    
    
    1.2
    
    
    
    7.1
    
    
    
    4.5
    
    
    
    3.1
    
    
    
    3.4
    
    
    
    2.7Preferred stock dividend (pre-tax equivalent)
    
    
    0.1
    
    
    
    0.3
    
    
    
    0.5
    
    
    
    0.5
    
    
    
    33.8
    
    
    
    9.2Interest component of rent expense
    
    
    1.2
    
    
    
    4.8
    
    
    
    3.6
    
    
    
    2.8
    
    
    
    3.0
    
    
    
    2.5TOTAL FIXED CHARGES, AS DEFINED
    
    $
    23.8
    
    
    $
    73.2
    
    
    $
    52.5
    
    
    $
    43.3
    
    
    $
    76.7
    
    
    $
    49.4RATIO OF EARNINGS TO FIXED CHARGES
    
    
    4.1
    
    
    
    5.6
    
    
    
    6.9
    
    
    
    5.7
    
    
    
    1.4
    
    
    
    1.2
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the meetings.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable materials, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         Biomedical Library and Informatics Review Committee.                    

*Date:*                         November 2-3, 2017.                    

*Time:*                         November 2, 2017, 8:00 a.m. to 6:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Bethesda Marriott Suites, 6711 Democracy Boulevard, Bethesda, MD 20817.                    

*Time:*                         November 3, 2017, 8:00 a.m. to 6:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Contact Person:*                         Joseph Rudolph, Ph.D., Acting Scientific Review Officer, NLM, Chief and Scientific Review Officer, CSR, Center for Scientific Review, NIH, 6701 Rockledge Drive, Room 5216, Bethesda, MD 20817, 301-408-9098,                         *josephru@mail.nih.gov.*

(Catalogue of Federal Domestic Assistance Program No. 93.879, Medical Library Assistance, National Institutes of Health, HHS)

Dated: August 15, 2017.

Michelle Trout,

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2017-17542 Filed 8-18-17; 8:45 am]

 BILLING CODE 4140-01-P
Exhibit 31.1


                                 CERTIFICATIONS

I, Donald P. Gill, hereby certify that:

(1) I have reviewed this quarterly report on Form 10-QSB of First Ipswich
Bancorp;

(2) Based on my knowledge, this quarterly report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to make
the statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this quarterly
report;

(3) Based on my knowledge, the financial statements, and other financial
information included in this quarterly report, fairly present in all material
respects the financial condition, results of operations and cash flows of the
small business issuer as of, and for, the periods presented in this quarterly
report;

(4) The small business issuer's other certifying officer and I are responsible
for establishing and maintaining disclosure controls and procedures (as defined
in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the small business issuer and
we have:

      a) Designed such disclosure controls and procedures, or caused such
      disclosure controls and procedures to be designed under our supervision,
      to ensure that material information relating to the small business issuer,
      including its consolidated subsidiaries, is made known to us by others
      within those entities, particularly during the period in which this
      quarterly report is being prepared;

      b) Evaluated the effectiveness of the small business issuer's disclosure
      controls and procedures and presented in this quarterly report our
      conclusions about the effectiveness of the disclosure controls and
      procedures, as of the end of the period covered by this quarterly report
      based on such evaluation; and

      c) Disclosed in this quarterly report any change in the small business
      issuer's internal control over financial reporting that occurred during
      the small business issuer's most recent fiscal quarter that has materially
      affected, or is reasonably likely to materially affect, the small business
      issuer's internal control over financial reporting; and

(5) The small business issuer's other certifying officer and I have disclosed,
based on our most recent evaluation of internal control over financial
reporting, to the small business issuer's auditors and the audit committee of
the small business issuer's board of directors (or persons fulfilling the
equivalent functions):

      a) All significant deficiencies and material weaknesses in the design or
      operation of internal control over financial reporting which are
      reasonably likely to adversely affect the small business issuer's ability
      to record, process, summarize and report financial information; and

      b) Any fraud, whether or not material, that involves management or other
      employees who have a significant role in the small business issuer's
      internal controls over financial reporting.


/s/ Donald P. Gill
-----------------------------------------------------
Donald P. Gill
Chief Executive Officer

June 24, 2004
<TABLE> <S> <C>

<ARTICLE>                     5

<S>                             <C>
<PERIOD-TYPE>                 12-mos
<FISCAL-YEAR-END>                     Jan-31-2000
<PERIOD-START>                        Feb-01-1999
<PERIOD-END>                          Jan-31-2000
<CASH>                                     964000
<SECURITIES>                                    0
<RECEIVABLES>                             5367000
<ALLOWANCES>                                50000
<INVENTORY>                              10606000
<CURRENT-ASSETS>                         17435000
<PP&E>                                    9412000
<DEPRECIATION>                            4950000
<TOTAL-ASSETS>                           22774000
<CURRENT-LIABILITIES>                     6224000
<BONDS>                                         0
<PREFERRED-MANDATORY>                           0
<PREFERRED>                                     0
<COMMON>                                  1595000
<OTHER-SE>                               11684000
<TOTAL-LIABILITY-AND-EQUITY>             22774000
<SALES>                                  23271000
<TOTAL-REVENUES>                         23271000
<CGS>                                    14920000
<TOTAL-COSTS>                            14920000
<OTHER-EXPENSES>                          7295000
<LOSS-PROVISION>                                0
<INTEREST-EXPENSE>                         416000
<INCOME-PRETAX>                            482000
<INCOME-TAX>                               222000
<INCOME-CONTINUING>                        260000
<DISCONTINUED>                                  0
<EXTRAORDINARY>                                 0
<CHANGES>                                       0
<NET-INCOME>                                    0
<EPS-BASIC>                                     0
<EPS-DILUTED>                                   0


</TABLE>
EXHIBIT 32.2





CERTIFICATION PURSUANT TO

18 U.S.C. §1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



In connection with the Quarterly Report of Universal Hospital Services, Inc. (the Company) on Form 10-Q for the period ended June 30, 2003 as filed with the
Securities and Exchange Commission on the date hereof (the Report), I, John A. Gappa, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
2002, that:



(1) The Report fully complies with the
requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and



(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



/s/    JOHN A. GAPPAJohn A. Gappa Senior Vice President and Chief Financial Officer August 8, 2003




22
**Exhibit 23.1**

**Consent of Independent Registered Public AccountingFirm**

The Board of Directors

Inamed Corporation:

Weconsent to the incorporation by reference in the registration statements (Nos.333-107528, 333-105021, 333-43072, 333-32226, 333-88541,333-38698 and 333-33498) on Forms S-3 and S-8 of InamedCorporation of our reports dated March 14, 2005, with respect to theconsolidated balance sheets of Inamed Corporation as of December 31, 2004and 2003, and the related consolidated statements of income, stockholders’equity and comprehensive income, and cash flows for each of the years in thethree-year period ended December 31, 2004, and the related financialstatement schedule II, management’s assessment of the effectiveness ofinternal control over financial reporting as of December 31, 2004 and theeffectiveness of internal control over financial reporting as of December 31,2004, which reports appear in the December 31, 2004 Annual Report on Form 10-Kof Inamed Corporation.
| /s/ KPMG LLP            |   |
|-------------------------|--------|
| Los Angeles, California |
| March 14, 2005     |

 

 

----
Exhibit 32.1

CERTIFICATION OF PERIODIC FINANCIAL REPORT

PURSUANT TO 18 U.S.C. SECTION 1350

The undersigned officer of Chittenden Corporation (the Company) hereby certifies that the Companys annual report on Form 10-K for the
period ended December 31, 2006 to which this certification is being furnished as an exhibit (the Report), as filed with the Securities and Exchange Commission on the date hereof, fully complies with the requirements of
Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, as amended (the Exchange Act), and that the information contained in the Report fairly presents, in all material respects, the financial condition and
results of operations of the Company. This certification is provided pursuant to 18 U.S.C. Section 1350 and Item 601(b)(32) of Regulation S-K (Item 601(b)(32)) promulgated under the Securities Act of 1933, as amended (the
Securities Act), and the Exchange Act. In accordance with clause (ii) of Item 601(b)(32), this certification (A) shall not be deemed filed for purposes of Section 18 of the Exchange Act, or otherwise
subject to the liability of that section, and (B) shall not be deemed to be incorporated by reference into any filing under the Securities Act or the Exchange Act, except to the extent that the Company specifically incorporates it by reference.

|                         |  |  |  |                                                
|------------------------ |  |  |  | -----------------------------------------------
|                         |  | 
|Dated: February 26, 2007 |  |  |  | /s/    PAUL A. PERRAULT                        
|                         |  |  |  | Chairman, President and Chief Executive Officer
EXHIBIT 99.4

CONSENT OF INTERNAL QUALIFIED RESERVES EVALUATOR

I
consent to the incorporation by reference in this annual report on Form 40-F of Talisman Energy Inc., which is being filed with the United States Securities and
Exchange Commission, of my Report on Reserves Data dated February 28, 2013, included in the 2012 Annual Information Form of Talisman Energy Inc. (the "AIF"), and to the references
to my name in the AIF.

I
also consent to the incorporation by reference in the following Registration Statements:



of
my Report on Reserves Data dated February 28, 2013 and to the references to my name in the AIF, which are incorporated by reference in this annual report on Form 40-F.

Calgary, Canada
March 6, 2013

By:

/s/ BRUCE DINGEMAN Bruce Dingeman
Internal Qualified Reserves Evaluator


---



QuickLinks
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION FROM THE TEMTEX INDUSTRIES,
INC. AND SUBSIDIARIES FINANCIAL STATEMENTS FOR THE TWELVE MONTHS ENDED AUGUST
31, 1998 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL
STATEMENTS.
</LEGEND>
       
<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          AUG-31-1998
<PERIOD-END>                               AUG-31-1998
<CASH>                                             407
<SECURITIES>                                         0
<RECEIVABLES>                                    5,890
<ALLOWANCES>                                       292
<INVENTORY>                                      9,077
<CURRENT-ASSETS>                                15,951
<PP&E>                                          29,869
<DEPRECIATION>                                  22,703
<TOTAL-ASSETS>                                  23,647
<CURRENT-LIABILITIES>                            5,113
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           718
<OTHER-SE>                                      15,570
<TOTAL-LIABILITY-AND-EQUITY>                    23,647
<SALES>                                         37,183
<TOTAL-REVENUES>                                37,183
<CGS>                                           27,045
<TOTAL-COSTS>                                   27,045
<OTHER-EXPENSES>                                  (68)
<LOSS-PROVISION>                                   107
<INTEREST-EXPENSE>                                 464
<INCOME-PRETAX>                                    830
<INCOME-TAX>                                       323
<INCOME-CONTINUING>                                507
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                       507
<EPS-PRIMARY>                                      .15
<EPS-DILUTED>                                      .14
        

</TABLE>